Biogen Idec Investors
Biogen Idec is an American biotechnology company that provides therapeutics for neurological, autoimmune, and rare diseases.
.jpg)
.jpg)
Industry:
Biotechnology, Health Care, Neuroscience, Therapeutics
Technology:
NeuroPharmacology
Funding Status:
IPO
Investment Stage:
Early Stage Venture, Late Stage Venture
Estimated Revenue:
$1B to $10B
Acquisitions Number:
9
Headquarters:
Weston, Massachusetts, United States
Employee Number:
5001-10000
Number Of Exists:
15
Investor Type:
Venture Capital
Founded Date:
1978